[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global IVD Antibodies Market Growth (Status and Outlook) 2023-2029

March 2023 | 85 pages | ID: GBA3A09A8978EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In vitro diagnostics tests are used in laboratories, healthcare settings or directly by consumers at home for the detection of various diseases, infections and other medical conditions. Various companies in the IVD antibodies market are focusing on mergers and acquisitions with regional players. For example, in Sep. 2018, Summa Equity AB acquired Turku-based HyTest Ltd. whose regional presence in the U.S. and Asia is good. Continuously evolving nature of IVD antibodies market further expected to get maximum traction. Superior capability of the IVD antibodies to detect complex diseases such as cancer and use of IVD antibodies in therapeutic monitoring, evaluating blood safety before transfusion further makes it preferred choice of diagnosis test.

LPI (LP Information)' newest research report, the “IVD Antibodies Industry Forecast” looks at past sales and reviews total world IVD Antibodies sales in 2022, providing a comprehensive analysis by region and market sector of projected IVD Antibodies sales for 2023 through 2029. With IVD Antibodies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IVD Antibodies industry.

This Insight Report provides a comprehensive analysis of the global IVD Antibodies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IVD Antibodies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global IVD Antibodies market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IVD Antibodies and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IVD Antibodies.

The global IVD Antibodies market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for IVD Antibodies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for IVD Antibodies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for IVD Antibodies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key IVD Antibodies players cover Abcam, Thermo Fisher Scientific, Rockland Immunochemicals, GenScript, Bio-Rad Laboratories, SDIX, MEDICAL & BIOLOGICAL LABORATORIES, HyTest and Abbott, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of IVD Antibodies market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
  • Cardiac Markers
  • Tumor Markers
  • Kidney Injury Markers
Segmentation by application
  • Hospital
  • Specialty Clinic
  • Diagnostic Center
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Abcam
  • Thermo Fisher Scientific
  • Rockland Immunochemicals
  • GenScript
  • Bio-Rad Laboratories
  • SDIX
  • MEDICAL & BIOLOGICAL LABORATORIES
  • HyTest
  • Abbott
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global IVD Antibodies Market Size 2018-2029
  2.1.2 IVD Antibodies Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 IVD Antibodies Segment by Type
  2.2.1 Cardiac Markers
  2.2.2 Tumor Markers
  2.2.3 Kidney Injury Markers
2.3 IVD Antibodies Market Size by Type
  2.3.1 IVD Antibodies Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global IVD Antibodies Market Size Market Share by Type (2018-2023)
2.4 IVD Antibodies Segment by Application
  2.4.1 Hospital
  2.4.2 Specialty Clinic
  2.4.3 Diagnostic Center
  2.4.4 Others
2.5 IVD Antibodies Market Size by Application
  2.5.1 IVD Antibodies Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global IVD Antibodies Market Size Market Share by Application (2018-2023)

3 IVD ANTIBODIES MARKET SIZE BY PLAYER

3.1 IVD Antibodies Market Size Market Share by Players
  3.1.1 Global IVD Antibodies Revenue by Players (2018-2023)
  3.1.2 Global IVD Antibodies Revenue Market Share by Players (2018-2023)
3.2 Global IVD Antibodies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 IVD ANTIBODIES BY REGIONS

4.1 IVD Antibodies Market Size by Regions (2018-2023)
4.2 Americas IVD Antibodies Market Size Growth (2018-2023)
4.3 APAC IVD Antibodies Market Size Growth (2018-2023)
4.4 Europe IVD Antibodies Market Size Growth (2018-2023)
4.5 Middle East & Africa IVD Antibodies Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas IVD Antibodies Market Size by Country (2018-2023)
5.2 Americas IVD Antibodies Market Size by Type (2018-2023)
5.3 Americas IVD Antibodies Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC IVD Antibodies Market Size by Region (2018-2023)
6.2 APAC IVD Antibodies Market Size by Type (2018-2023)
6.3 APAC IVD Antibodies Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe IVD Antibodies by Country (2018-2023)
7.2 Europe IVD Antibodies Market Size by Type (2018-2023)
7.3 Europe IVD Antibodies Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa IVD Antibodies by Region (2018-2023)
8.2 Middle East & Africa IVD Antibodies Market Size by Type (2018-2023)
8.3 Middle East & Africa IVD Antibodies Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL IVD ANTIBODIES MARKET FORECAST

10.1 Global IVD Antibodies Forecast by Regions (2024-2029)
  10.1.1 Global IVD Antibodies Forecast by Regions (2024-2029)
  10.1.2 Americas IVD Antibodies Forecast
  10.1.3 APAC IVD Antibodies Forecast
  10.1.4 Europe IVD Antibodies Forecast
  10.1.5 Middle East & Africa IVD Antibodies Forecast
10.2 Americas IVD Antibodies Forecast by Country (2024-2029)
  10.2.1 United States IVD Antibodies Market Forecast
  10.2.2 Canada IVD Antibodies Market Forecast
  10.2.3 Mexico IVD Antibodies Market Forecast
  10.2.4 Brazil IVD Antibodies Market Forecast
10.3 APAC IVD Antibodies Forecast by Region (2024-2029)
  10.3.1 China IVD Antibodies Market Forecast
  10.3.2 Japan IVD Antibodies Market Forecast
  10.3.3 Korea IVD Antibodies Market Forecast
  10.3.4 Southeast Asia IVD Antibodies Market Forecast
  10.3.5 India IVD Antibodies Market Forecast
  10.3.6 Australia IVD Antibodies Market Forecast
10.4 Europe IVD Antibodies Forecast by Country (2024-2029)
  10.4.1 Germany IVD Antibodies Market Forecast
  10.4.2 France IVD Antibodies Market Forecast
  10.4.3 UK IVD Antibodies Market Forecast
  10.4.4 Italy IVD Antibodies Market Forecast
  10.4.5 Russia IVD Antibodies Market Forecast
10.5 Middle East & Africa IVD Antibodies Forecast by Region (2024-2029)
  10.5.1 Egypt IVD Antibodies Market Forecast
  10.5.2 South Africa IVD Antibodies Market Forecast
  10.5.3 Israel IVD Antibodies Market Forecast
  10.5.4 Turkey IVD Antibodies Market Forecast
  10.5.5 GCC Countries IVD Antibodies Market Forecast
10.6 Global IVD Antibodies Forecast by Type (2024-2029)
10.7 Global IVD Antibodies Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Abcam
  11.1.1 Abcam Company Information
  11.1.2 Abcam IVD Antibodies Product Offered
  11.1.3 Abcam IVD Antibodies Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Abcam Main Business Overview
  11.1.5 Abcam Latest Developments
11.2 Thermo Fisher Scientific
  11.2.1 Thermo Fisher Scientific Company Information
  11.2.2 Thermo Fisher Scientific IVD Antibodies Product Offered
  11.2.3 Thermo Fisher Scientific IVD Antibodies Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Thermo Fisher Scientific Main Business Overview
  11.2.5 Thermo Fisher Scientific Latest Developments
11.3 Rockland Immunochemicals
  11.3.1 Rockland Immunochemicals Company Information
  11.3.2 Rockland Immunochemicals IVD Antibodies Product Offered
  11.3.3 Rockland Immunochemicals IVD Antibodies Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Rockland Immunochemicals Main Business Overview
  11.3.5 Rockland Immunochemicals Latest Developments
11.4 GenScript
  11.4.1 GenScript Company Information
  11.4.2 GenScript IVD Antibodies Product Offered
  11.4.3 GenScript IVD Antibodies Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 GenScript Main Business Overview
  11.4.5 GenScript Latest Developments
11.5 Bio-Rad Laboratories
  11.5.1 Bio-Rad Laboratories Company Information
  11.5.2 Bio-Rad Laboratories IVD Antibodies Product Offered
  11.5.3 Bio-Rad Laboratories IVD Antibodies Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Bio-Rad Laboratories Main Business Overview
  11.5.5 Bio-Rad Laboratories Latest Developments
11.6 SDIX
  11.6.1 SDIX Company Information
  11.6.2 SDIX IVD Antibodies Product Offered
  11.6.3 SDIX IVD Antibodies Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 SDIX Main Business Overview
  11.6.5 SDIX Latest Developments
11.7 MEDICAL & BIOLOGICAL LABORATORIES
  11.7.1 MEDICAL & BIOLOGICAL LABORATORIES Company Information
  11.7.2 MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Product Offered
  11.7.3 MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 MEDICAL & BIOLOGICAL LABORATORIES Main Business Overview
  11.7.5 MEDICAL & BIOLOGICAL LABORATORIES Latest Developments
11.8 HyTest
  11.8.1 HyTest Company Information
  11.8.2 HyTest IVD Antibodies Product Offered
  11.8.3 HyTest IVD Antibodies Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 HyTest Main Business Overview
  11.8.5 HyTest Latest Developments
11.9 Abbott
  11.9.1 Abbott Company Information
  11.9.2 Abbott IVD Antibodies Product Offered
  11.9.3 Abbott IVD Antibodies Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Abbott Main Business Overview
  11.9.5 Abbott Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. IVD Antibodies Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Cardiac Markers
Table 3. Major Players of Tumor Markers
Table 4. Major Players of Kidney Injury Markers
Table 5. IVD Antibodies Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global IVD Antibodies Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global IVD Antibodies Market Size Market Share by Type (2018-2023)
Table 8. IVD Antibodies Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global IVD Antibodies Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global IVD Antibodies Market Size Market Share by Application (2018-2023)
Table 11. Global IVD Antibodies Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global IVD Antibodies Revenue Market Share by Player (2018-2023)
Table 13. IVD Antibodies Key Players Head office and Products Offered
Table 14. IVD Antibodies Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global IVD Antibodies Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global IVD Antibodies Market Size Market Share by Regions (2018-2023)
Table 19. Global IVD Antibodies Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global IVD Antibodies Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas IVD Antibodies Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas IVD Antibodies Market Size Market Share by Country (2018-2023)
Table 23. Americas IVD Antibodies Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas IVD Antibodies Market Size Market Share by Type (2018-2023)
Table 25. Americas IVD Antibodies Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas IVD Antibodies Market Size Market Share by Application (2018-2023)
Table 27. APAC IVD Antibodies Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC IVD Antibodies Market Size Market Share by Region (2018-2023)
Table 29. APAC IVD Antibodies Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC IVD Antibodies Market Size Market Share by Type (2018-2023)
Table 31. APAC IVD Antibodies Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC IVD Antibodies Market Size Market Share by Application (2018-2023)
Table 33. Europe IVD Antibodies Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe IVD Antibodies Market Size Market Share by Country (2018-2023)
Table 35. Europe IVD Antibodies Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe IVD Antibodies Market Size Market Share by Type (2018-2023)
Table 37. Europe IVD Antibodies Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe IVD Antibodies Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa IVD Antibodies Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa IVD Antibodies Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa IVD Antibodies Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa IVD Antibodies Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa IVD Antibodies Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa IVD Antibodies Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of IVD Antibodies
Table 46. Key Market Challenges & Risks of IVD Antibodies
Table 47. Key Industry Trends of IVD Antibodies
Table 48. Global IVD Antibodies Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global IVD Antibodies Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global IVD Antibodies Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global IVD Antibodies Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Abcam Details, Company Type, IVD Antibodies Area Served and Its Competitors
Table 53. Abcam IVD Antibodies Product Offered
Table 54. Abcam IVD Antibodies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Abcam Main Business
Table 56. Abcam Latest Developments
Table 57. Thermo Fisher Scientific Details, Company Type, IVD Antibodies Area Served and Its Competitors
Table 58. Thermo Fisher Scientific IVD Antibodies Product Offered
Table 59. Thermo Fisher Scientific Main Business
Table 60. Thermo Fisher Scientific IVD Antibodies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Thermo Fisher Scientific Latest Developments
Table 62. Rockland Immunochemicals Details, Company Type, IVD Antibodies Area Served and Its Competitors
Table 63. Rockland Immunochemicals IVD Antibodies Product Offered
Table 64. Rockland Immunochemicals Main Business
Table 65. Rockland Immunochemicals IVD Antibodies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Rockland Immunochemicals Latest Developments
Table 67. GenScript Details, Company Type, IVD Antibodies Area Served and Its Competitors
Table 68. GenScript IVD Antibodies Product Offered
Table 69. GenScript Main Business
Table 70. GenScript IVD Antibodies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. GenScript Latest Developments
Table 72. Bio-Rad Laboratories Details, Company Type, IVD Antibodies Area Served and Its Competitors
Table 73. Bio-Rad Laboratories IVD Antibodies Product Offered
Table 74. Bio-Rad Laboratories Main Business
Table 75. Bio-Rad Laboratories IVD Antibodies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Bio-Rad Laboratories Latest Developments
Table 77. SDIX Details, Company Type, IVD Antibodies Area Served and Its Competitors
Table 78. SDIX IVD Antibodies Product Offered
Table 79. SDIX Main Business
Table 80. SDIX IVD Antibodies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. SDIX Latest Developments
Table 82. MEDICAL & BIOLOGICAL LABORATORIES Details, Company Type, IVD Antibodies Area Served and Its Competitors
Table 83. MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Product Offered
Table 84. MEDICAL & BIOLOGICAL LABORATORIES Main Business
Table 85. MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. MEDICAL & BIOLOGICAL LABORATORIES Latest Developments
Table 87. HyTest Details, Company Type, IVD Antibodies Area Served and Its Competitors
Table 88. HyTest IVD Antibodies Product Offered
Table 89. HyTest Main Business
Table 90. HyTest IVD Antibodies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. HyTest Latest Developments
Table 92. Abbott Details, Company Type, IVD Antibodies Area Served and Its Competitors
Table 93. Abbott IVD Antibodies Product Offered
Table 94. Abbott Main Business
Table 95. Abbott IVD Antibodies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Abbott Latest Developments

LIST OF FIGURES

Figure 1. IVD Antibodies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global IVD Antibodies Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. IVD Antibodies Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. IVD Antibodies Sales Market Share by Country/Region (2022)
Figure 8. IVD Antibodies Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global IVD Antibodies Market Size Market Share by Type in 2022
Figure 10. IVD Antibodies in Hospital
Figure 11. Global IVD Antibodies Market: Hospital (2018-2023) & ($ Millions)
Figure 12. IVD Antibodies in Specialty Clinic
Figure 13. Global IVD Antibodies Market: Specialty Clinic (2018-2023) & ($ Millions)
Figure 14. IVD Antibodies in Diagnostic Center
Figure 15. Global IVD Antibodies Market: Diagnostic Center (2018-2023) & ($ Millions)
Figure 16. IVD Antibodies in Others
Figure 17. Global IVD Antibodies Market: Others (2018-2023) & ($ Millions)
Figure 18. Global IVD Antibodies Market Size Market Share by Application in 2022
Figure 19. Global IVD Antibodies Revenue Market Share by Player in 2022
Figure 20. Global IVD Antibodies Market Size Market Share by Regions (2018-2023)
Figure 21. Americas IVD Antibodies Market Size 2018-2023 ($ Millions)
Figure 22. APAC IVD Antibodies Market Size 2018-2023 ($ Millions)
Figure 23. Europe IVD Antibodies Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa IVD Antibodies Market Size 2018-2023 ($ Millions)
Figure 25. Americas IVD Antibodies Value Market Share by Country in 2022
Figure 26. United States IVD Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada IVD Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico IVD Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil IVD Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC IVD Antibodies Market Size Market Share by Region in 2022
Figure 31. APAC IVD Antibodies Market Size Market Share by Type in 2022
Figure 32. APAC IVD Antibodies Market Size Market Share by Application in 2022
Figure 33. China IVD Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan IVD Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea IVD Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia IVD Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 37. India IVD Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia IVD Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe IVD Antibodies Market Size Market Share by Country in 2022
Figure 40. Europe IVD Antibodies Market Size Market Share by Type (2018-2023)
Figure 41. Europe IVD Antibodies Market Size Market Share by Application (2018-2023)
Figure 42. Germany IVD Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 43. France IVD Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK IVD Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy IVD Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia IVD Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa IVD Antibodies Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa IVD Antibodies Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa IVD Antibodies Market Size Market Share by Application (2018-2023)
Figure 50. Egypt IVD Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa IVD Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel IVD Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey IVD Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country IVD Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 56. APAC IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 57. Europe IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 59. United States IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 60. Canada IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 61. Mexico IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 62. Brazil IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 63. China IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 64. Japan IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 65. Korea IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 67. India IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 68. Australia IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 69. Germany IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 70. France IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 71. UK IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 72. Italy IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 73. Russia IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 74. Spain IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 75. Egypt IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 76. South Africa IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 77. Israel IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 78. Turkey IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries IVD Antibodies Market Size 2024-2029 ($ Millions)
Figure 80. Global IVD Antibodies Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global IVD Antibodies Market Size Market Share Forecast by Application (2024-2029)


More Publications